|
2024
|
Invention
|
Stable, concentrated radionuclide complex solutions.
The present invention relates to radionucli... |
|
|
Invention
|
Neutron activator, neutron activation system comprising such neutron activator and method for neu... |
|
|
Invention
|
Accelerator-drivenneutron activator for bachytherapy.
A neutron activator for neutron activation... |
|
|
Invention
|
Stable, concentrated radionuclide complex solutions. The present invention relates to radionuclid... |
|
|
Invention
|
Method of treatment of neuroendocrine tumors.
The present invention relates to methods of treati... |
|
2023
|
Invention
|
Accelerator-driven neutron activator for brachytherapy.
A neutron activator for neutron activati... |
|
|
Invention
|
Methods for large scale synthesis of radionuclide complexes. The present disclosure relates to me... |
|
2022
|
Invention
|
Combination therapy for treating lung cancer.
The present invention relates to methods for treat... |
|
|
Invention
|
Combination therapy for treating lung cancer. The present invention relates to methods fortreatin... |
|
|
Invention
|
Combination therapy of radionuclide complex. The present disclosure is directed to a method of tr... |
|
|
Invention
|
Method of treatment of neuroendocrine tumors that over-express somatostatatin receptors.
The pre... |
|
2021
|
Invention
|
Method for producing high purity and high specific activity radionuclides.
The invention relates... |
|
2020
|
Invention
|
Method of treating cancer by intratumoral deposition of radioactive microparticles.
A compositio... |
|
2019
|
Invention
|
Neutron activator includes a metallic plate target configured to produce protons through interact... |
|
2018
|
Invention
|
New nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precurs... |
|
|
Invention
|
Accelerator-driven neutron activator for brachytherapy. a Beryllium first reflector-moderator (4)... |
|
2017
|
Invention
|
Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precursors ... |
|
2016
|
Invention
|
Method of treatment of neuroendocrine tumors that over-express somatostatatin receptors. The pres... |
|
2014
|
Invention
|
Compounds modulators of vegf activity and uses thereof. Compounds of general formula (1): X1Y1X2Y... |
|
2013
|
Invention
|
Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio) molecules; precursors... |
|
|
Invention
|
3 receptor peptide antagonist for therapeutic and diagnostic applications. 3-targeted therapy and... |
|
2010
|
Invention
|
Sultone compound derivatives substituted by nucleophiles, in particular radionuclides, and use th... |
|
|
Invention
|
Use of microrna-199b-5p in medical and diagnostic field. This invention concerns the use of Micro... |
|
2009
|
Invention
|
Dicarba-analogues of octreotide.
Analogues of octreotide, their preparation and use are described. |
|
|
Invention
|
Peptides and their use as carriers into cancer cells. The use of a peptide is described as a carr... |
|
|
Invention
|
Peptides and their use as carriers into cancer cells. The use of a peptide is described as... |
|
2007
|
Invention
|
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ... |
|
2006
|
Invention
|
Escherichia coli . Escherichia coli.
Escherichia coli to an industrial level.
|
